Market positioning Target hospital and health system laboratories that require rapid molecular diagnostics and antibiotic resistance gene testing, leveraging Ipsum Diagnostics’ PCR-based panels and integrated reporting to differentiate from larger regional players.

Growth opportunities Collaboration with mid-sized health networks and independent labs seeking scalable, customized reporting, EMR integration, and mobile access to expand their diagnostic capabilities and improve turnaround times.

Technology leverage Highlight the value of Ipsum’s software-enabled, user-friendly reports and data analytics for treatment performance and population health insights to hospitals investing in data-driven care and outcomes measurement.

Expansion channels Upsell service tiers such as Spanish-language patient portal expansion, workflow customization, and flexible specimen logistics to facilities serving diverse patient populations and multilingual communities.

Competitive edge Position as a niche, agile molecular diagnostics partner with personalized service and rapid reporting, appealing to facilities seeking high-touch vendor relationships and faster path to actionable results.